BIOMARIN PHARMACEUTICAL INC (BMRN) Operating Lease, Liability USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Biomarin Pharmaceutical Inc quarterly Operating Lease, Liability history and growth rate from 2019 to 2023.
  • Biomarin Pharmaceutical Inc Operating Lease, Liability for the quarter ending December 31, 2023 was $46.7 M, a 35.7% increase year-over-year.
Operating Lease, Liability, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $46.7 M +$12.3 M +35.7% Dec 31, 2023 10-K 2024-02-26
Q4 2022 $34.4 M -$5.66 M -14.1% Dec 31, 2022 10-K 2023-02-27
Q4 2021 $40.1 M -$9.29 M -18.8% Dec 31, 2021 10-K 2022-02-25
Q4 2020 $49.4 M -$2.17 M -4.21% Dec 31, 2020 10-K 2021-02-26
Q3 2020 $48.6 M -$4.13 M -7.82% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $49.9 M -$3.3 M -6.21% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $51.6 M +$6.01 M +13.2% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $51.5 M Dec 31, 2019 10-K 2020-02-27
Q3 2019 $52.8 M Sep 30, 2019 10-Q/A 2019-11-04
Q2 2019 $53.2 M Jun 30, 2019 10-Q 2019-08-02
Q1 2019 $45.6 M Mar 31, 2019 10-Q 2019-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.